Jakarta. MRCCC Siloam Hospitals Semanggi launches Southeast Asia’s first integrated CT-LINAC cancer treatment system powered by artificial intelligence, offering advanced radiotherapy locally and reducing the need for Indonesian patients to seek treatment abroad.

CT-LINAC is a next-generation precision radiotherapy platform that integrates diagnostic CT imaging with a linear accelerator (LINAC) in a single system, enabling faster, more accurate, and adaptive cancer treatment. By combining conventional LINAC radiotherapy with CT scanning, the system allows clinicians to identify tumor targets and surrounding healthy organs layer by layer. Supported by artificial intelligence, it assists doctors in delineating treatment areas, optimizing radiation planning, and delivering therapy with greater confidence and speed.

The system was unveiled at an event titled “Advanced Precision Seamless Care: Leading the Future of Radiotherapy for a Better Healing” at MRCCC Siloam Semanggi in South Jakarta on Thursday. The launch makes the facility the only hospital in Indonesia to operate the AI-based CT-LINAC, developed through a collaboration with China-based United Imaging Healthcare.

The event was attended by Mochtar Riady, founder and chairman of the Lippo Group; Caroline Riady, CEO of Siloam International Hospitals; Wang Siping, counselor at the Chinese Embassy in Indonesia; Dr. Obrin Parulian, director of clinical services at the Health Ministry; Dr. Jusong Xia, president of international business at United Imaging Healthcare Group; and Dr. Edy Gunawan, executive director of MRCCC Siloam Semanggi.

“The integrated CT-LINAC is not just a machine. It is a symbol of what we believe in, of what we are capable of, and of where oncology in Indonesia can go next,” Caroline Riady said.

Unlike conventional radiotherapy, which generally has a long workflow that can take weeks, the Integrated CT-LINAC simplifies the entire therapy process into a single session without the need to reposition the patient, with preparation and irradiation time taking around 15-25 minutes. The all-in-one system is designed to treat a range of complex cancers, including brain, lung, liver, cervical, breast, prostate, and nasopharyngeal cancers, where high levels of precision are particularly critical.

Health Ministry official Dr. Obrin Parulian said AI-integrated radiotherapy offers significant benefits amid Indonesia’s growing cancer burden but also requires strong human resource capacity.

“We recognize the challenges associated with this technology. CT-LINAC integration demands well-trained, multidisciplinary teams who understand advanced systems, quality assurance, and patient safety,” he said.

Dr. Denny Handoyo Kirana, a radiation oncologist at MRCCC Siloam Semanggi, said patients stand to benefit from the system’s efficiency and accuracy.

“Through daily CT imaging and adaptive radiotherapy, each session can be tailored to the patient’s current anatomy and condition,” he said. “This improves precision while reducing unnecessary radiation exposure to healthy tissue.”

According to data from the Global Cancer Observatory (GLOBOCAN) 2022, breast cancer is the most common cancer in Indonesia, with 66,271 new cases, accounting for 16.2 percent of all cancer cases. The disease caused 22,598 deaths, with a five-year prevalence of 209,748 cases among Indonesian women.